Overview

Pulmonary Interstitial Lymphography in Early Stage Lung Cancer

Status:
Terminated
Trial end date:
2017-04-30
Target enrollment:
Participant gender:
Summary
The stereotactic body radiation therapy (SBRT) procedure is an emerging alternative to the standard treatment for early stage non-small cell lung cancer (NSCLC), typically lobectomy with lymphadenectomy. This procedure (lobectomy) does not fulfill the medical need as many patients are poor operative candidates or decline surgery. This study assesses the feasibility of stereotactic body radiation therapy (SBRT) as a tool to produce therapeutically useful computed tomography (CT) scans, using standard water-soluble iodinated compounds as the contrast agents.
Phase:
N/A
Details
Lead Sponsor:
Stanford University